Schonfeld Strategic Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Schonfeld Strategic Advisors's LLY Position: Q2 2026 in Review
Schonfeld Strategic Advisors increased its Eli Lilly (LLY) stake by 816% in Q2 2026, buying an estimated $219M and bringing the position to 240,327 shares worth $48.5M. The position accounts for 0.17% of the portfolio, ranked #96.
Schonfeld Strategic Advisors first reported a position in LLY in Q4 2016 and has held it in 30 quarters since. The position peaked at $74.1M in Q2 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Schonfeld Strategic Advisors held 240,327 shares of Eli Lilly worth $48.5M as of Q2 2026.
- Schonfeld Strategic Advisors bought 214,090 Eli Lilly shares in Q2 2026, an estimated $219M.
- Eli Lilly made up 0.17% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #96 holding.
- Schonfeld Strategic Advisors first reported a position in Eli Lilly in Q4 2016 and has held it in 30 quarters since.
- Schonfeld Strategic Advisors's Eli Lilly position peaked at $74.1M in Q2 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.